Executive Team
Malik Jainudeen
Acting Chief Executive Officer
Mr Malik Jainudeen was appointed to the role of Acting Chief Executive Officer for Monash IVF Group on 12 June 2025.
Malik joined Monash IVF Group in 2014 as a senior finance leader and has steadily progressed his career within the organisation. He has held the role of Chief Financial Officer and Company Secretary since 2019, contributing significantly to the Group’s financial strategy and governance.
Throughout his tenure, Malik has been instrumental in navigating complex regulatory environments, strengthening corporate governance, and enhancing operational efficiency, ensuring continued alignment with ASX compliance requirements and shareholder expectations.
With over 20 years of experience in the finance sector, Malik previously spent 10 years at KPMG as a Manager in Audit and Assurance. During this time, he managed audit engagements for several ASX-listed companies, including Origin Energy Limited, AusNet Services, and Dulux Group Limited. Prior to joining Monash IVF Group, he served as its External Audit Manager for six years leading up to the company’s listing on the ASX in 2014.
Malik holds a Bachelor of Business and is a qualified Chartered Accountant.
Rebecca Redden
Chief Operating Officer
Since joining Monash IVF Group in 2018, Rebecca Redden has held senior leadership roles, including Interim Operations Officer for the Southwest Coast and Diagnostics, and Regional Manager across South Australia, the Northern Territory, and national Diagnostics services. She has been instrumental in improving operational performance, service delivery, and patient-centred care.
With over 25 years in healthcare, Rebecca combines clinical and business management expertise. Originally trained as a Diagnostic Medical Sonographer, she has held senior clinical roles in both public and private sectors across Australia and the UK, specialising in fertility, obstetric, and gynaecological imaging.
At Monash IVF, she has led strategic initiatives across multiple business units, driving efficiency, collaboration, and growth. Rebecca holds a Bachelor of Medical Radiations and a Diploma in Diagnostic Medical Sonography, and is recognised for her leadership in healthcare operations, service transformation, and team development.
Andrew MacLachlan
Interim Chief Financial Officer
Mr Andrew MacLachlan was appointed Interim Chief Financial Officer for Monash IVF Group on 16th July 2025.
Mr MacLachlan has extensive financial experience in ASX listed companies, having previously served as CFO for MUFG Pension & Market Services Holdings Limited (formerly Link Administration Holdings Limited) and other CFO and senior finance roles in other listed and non-listed companies.
Tedd Fuell
Chief Governance & Risk Officer
Ms Tedd Fuell joined the Monash IVF Group in February 2016 as the Group Quality, Risk & Compliance Manager.
Tedd has spent the last 16 years in the fertility industry, navigating the complex regulatory framework and advocating for reforms that eliminate discrimination, promote access to care and promote patient safety outcomes.
Before moving to Australia in 2009, Tedd gained her experience in quality, compliance and risk in both pharmaceutical project management and quality and compliance roles. Tedd holds a Bachelor of Science (Biology) degree from the University of London.
Thierry Panthier
Chief Information Officer
Mr Thierry Panthier joined Monash IVF Group in May 2019.
Thierry is responsible for continuing and expanding the Group’s digital transformation and cyber security initiatives.
Before joining the company Thierry worked in management roles for Mediaocean and Faiveley Transport.
Peggy North
Chief Corporate Shared Services Officer
Ms Peggy North joined the Monash IVF Group as Group Human Resources Manager in March 2017.
In her 16 years as a Human Resources specialist, she has worked in large multinational, public and private companies, developing HR action plans; designing, leading and facilitating change processes; applying change management methodologies; and, developing recommendations to promote HR policy, cultural and procedural change.
Prior to joining the Group, Peggy gained her Human Resources experience working for leading Australian and International FMCG organisations.
Peggy holds a Bachelor’s degree of Commerce, Human Resources Management and Services from the Swinburne University of Technology in Melbourne and is currently undertaking her MBA.
Prof Deidre Zander-Fox
Chief Scientific Officer
Prof Deirdre Zander-Fox is currently the Monash IVF Group Chief Scientific Officer. She is responsible for the scientific and research strategy the Monash IVF Group and chair of the Group Scientific Advisory Committee.
In addition to her clinical roles, she also holds multiple academic positions including Adjunct Professor at Monash University and A/Prof at the University of Adelaide.
She is a investigator on several NHMRC grants including the successful $15million MRFF grant to pilot Mitochondrial donation in Australia as part of a clinical trial. Professor Zander-Fox has authored a substantial number of peer-reviewed journal articles and book chapters with her research primarily focusing on designing and improving laboratory technology to increase the success of IVF treatment outcomes for patients
Prof Luk Rombauts
Group Medical Director
Prof Luk Rombauts joined the Monash IVF Group in 1999, becoming Group Medical Director in 2016. Luk also holds positions as the Research Director at Monash IVF, Adjunct Clinical Professor at Monash University and Clinical Research Director of the Endometriosis Care Centre of Australia (ECCA).
Luk is also the Vice-President of the Fertility Society of Australia (FSA) where he was appointed in 2011.
He is also a Research Fellow of the Hudson Institute of Medical Research, where he is conducting research funded by the National Health and Medical Research Council in the fields of endometriosis and embryo implantation.
Johannes Lagerwij
Asia Managing Director
Mr Johannes “Jan” Lagerwij joined Monash IVF Group in March 2017 as the Asia Managing Director.
Jan’s role is to further strengthen the organisation’s footprint in international markets by identifying and executing potential overseas partnerships and acquisitions to grow and expand Monash IVF Group brand internationally. Jan comes with extensive global experience in mergers and acquisitions, joint ventures, co-development licensing and funding in the healthcare field.
Prior to his appointment with Monash IVF Group, he was an independent healthcare consultant advising strategic firms, venture capital and private equity in various strategic and transactional projects in China and Singapore.